Key result
Transcatheter autologous pulmonary valve replacement proves safe and feasible in sheep without paravalvular leak.
Why the study?
Clinical challenges such as stented heart valve deterioration, coronary occlusion, and endocarditis limit the lifetime application of transcatheter pulmonary valve replacement.
Does transcatheter autologous pulmonary valve replacement using a self-expandable Nitinol stent demonstrate feasibility and safety in an adult sheep model?
Does transcatheter autologous pulmonary valve replacement using a self-expandable Nitinol stent demonstrate feasibility and safety in an adult sheep model?
Transcatheter pulmonary valve replacement using autologous pericardium on a self-expandable Nitinol stent is feasible and safe in an adult sheep model, offering a potential lifelong solution for right ventricular outflow tract dysfunction.
Preclinical feasibility in sheep warrants human cadaveric or early-phase trials; leaves open durability and efficacy in diseased valves.
Transcatheter pulmonary valve replacement has been established as a viable alternative approach for patients suffering from right ventricular outflow tract or bioprosthetic valve dysfunction, with excellent early and late clinical outcomes. However, clinical challenges such as stented heart valve deterioration, coronary occlusion, endocarditis, and other complications must be addressed for lifetime application, particularly in pediatric patients. To facilitate the development of a lifelong solution for patients, transcatheter autologous pulmonary valve replacement was performed in an adult sheep model. The autologous pericardium was harvested from the sheep via left anterolateral minithoracotomy under general anesthesia with ventilation. The pericardium was placed on a 3D shaping heart valve model for non-toxic cross-linking for 2 days and 21 h. Intracardiac echocardiography (ICE) and angiography were performed to assess the position, morphology, function, and dimensions of the native pulmonary valve (NPV). After trimming, the crosslinked pericardium was sewn onto a self-expandable Nitinol stent and crimped into a self-designed delivery system. The autologous pulmonary valve (APV) was implanted at the NPV position via left jugular vein catheterization. ICE and angiography were repeated to evaluate the position, morphology, function, and dimensions of the APV. An APV was successfully implanted in sheep J. In this paper, sheep J was selected to obtain representative results. A 30 mm APV with a Nitinol stent was accurately implanted at the NPV position without any significant hemodynamic change. There was no paravalvular leak, no new pulmonary valve insufficiency, or stented pulmonary valve migration. This study demonstrated the feasibility and safety, in a long-time follow-up, of developing an APV for implantation at the NPV position with a self-expandable Nitinol stent via jugular vein catheterization in an adult sheep model.
No takes yet. Share an insight, caveat, or question.
Hao et al. (2022) studied Right ventricular outflow tract or bioprosthetic valve dysfunction (animal model). Transcatheter autologous pulmonary valve replacement with a self-expandable Nitinol stent was evaluated on Feasibility and safety (hemodynamic change, paravalvular leak, valve insufficiency, migration). Transcatheter autologous pulmonary valve replacement using a self-expandable Nitinol stent was feasible and safe in an adult sheep model, with no paravalvular leak or significant hemodynamic change.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: